3.05% Jul 23, 05:19 PM
$1.96 Paid Quarterly
70.3% EPS $2.79
No Payout Increase Last Year
21 days Aug 13, 2014

LLY - Upcoming Dividend Payouts
Next Ex-Dividend Date Aug 13

Amount Declare Date Ex-Dividend Date ▲ Record Date Pay Date Payout Type
$0.4900 2014-06-16 2014-08-13 2014-08-15 2014-09-10 Regular
Date has passed
Next Ex-Dividend Date
Next Pay Date

LLY - Dividend Yield & Stock Price History
Current Dividend Yield 3.05%

Arrow-right
5y
All

LLY - Dividend Payout History
Current Annual Payout $1.96

5y
All
Dividend payouts are split-adjusted

LLY - Dividend Growth History

Annualized Growth
1994-2012
Annualized Growth
1994-2004
Annualized Growth
2004-2008
Annualized Growth
2008-2012
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Annual
Growth
2012
Consecutive
Years of
Increases
Reveal Dividend Growth History for LLY. 0.0% 0.0% No Payout Increase Last Year
Annual dividend amounts based on Ex-dividend date

LLY - Historical Annual Dividend Data & Growth
Payouts Increasing For No Payout Increase Last Year

Payout Amount Calendar Year Annual Growth
$1.9600 2013 0.0%
$1.9600 2012 0.0%

LLY - Historical Dividend Data
Payouts Increasing For No Payout Increase Last Year

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
$0.4900 2014-06-16 2014-08-13 2014-08-15 2014-09-10 Unknown Regular Quarter
$0.4900 2014-05-05 2014-05-13 2014-05-15 2014-06-10 Yes Regular Quarter
$0.4900 2013-12-16 2014-02-12 2014-02-14 2014-03-10 Yes Regular Quarter
$0.4900 2013-10-21 2013-11-13 2013-11-15 2013-12-10 Yes Regular Quarter
$0.4900 2013-06-18 2013-08-13 2013-08-15 2013-09-10 Yes Regular Quarter

Eli Lilly (LLY) - News

  • There will be several notable second quarter earnings releases this week. Aside from dozens of major dividend payers slated to deliver results,...
  • Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its...
  • Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its...
  • Before Thursday's opening bell, a number of big name, dividend paying companies announced their quarterly earnings. Below, we look at these...
  • Before Monday's opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst...
  • Before Tuesday's opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst...
  • Eli Lilly and Co to Pay $3B in Fines in Actos Diabetes Drug Case (LLY)

    Late on Monday, a verdict came in that will require Eli Lilly (LLY) and its partner, Japan-based Takeda, to pay a combined total of $9 billion in a case related to the diabetes drug call Actos. The Actos case was based around Eli Lilly and Takeda concealing that there were cancer risks to the drug. Takeda will pay $6 billion while Eli Lilly will pay $3 billion. The case was decided by a jury in Lafayette, Louisiana. According to Bloomberg, Candace Johnson, a spokesperson for Eli Lilly, had the following comments about the verdict: "While we have empathy for the plaintiff, we believe the evidence did not support claims that Actos caused his bladder cancer. We intend to vigorously challenge this outcome through all available legal means, including possible post-trial motions and an appeal.” For more on big pharma companies, check out How Much Dividend-Paying Pharmaceutical Companies Spend on R&D Eli Lilly stock was down 39 cents, or 0.66%, in pre-market trading. YTD, the company's stock is up 15.55%.
    LLY Dividend Snapshot

    As of Market Close on April 6, 2014

    WMT dividend yield annual payout payout ratio dividend growth

    Click here to see the complete history of LLY dividends.

    The Bottom Line

    Eli Lilly (LLY)  is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

    Expand to read the full story »

  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Nabors Industries...
  • Before Wednesday's opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst...
  • Eli Lilly & Co. Gives 2014 Guidance; In Line with Analyst Estimates (LLY)

    On Tuesday morning, Eli Lilly & Co. (LLY) gave EPS and revenue guidance for 2014, and LLY's CEO and chairman made comments on the company's strategy for the future. Eli Lilly sees its EPS for the coming year in the range of $2.77 to $2.85; analysts' estimates fall in the lower side of this range. The company sees 2014 revenue in the range of $19.2 billion to $19.8 billion, while The Street sees revenue coming in at $19.55 billion. John C. Lechleiter, Ph.D., Lilly's chairman, president and CEO, had the following comments about Lilly's future performance and strategy: "We continue to focus on the three strategic priorities that have guided our efforts throughout an extended period of patent expirations. First and foremost, we are replenishing and advancing our pipeline. Today, we have 13 potential new medicines in Phase III testing or submission stage, with 26 more in Phase II. We anticipate obtaining regulatory approvals for and successfully launching multiple products each year for the next few years. At the same time, we aim to sustain strong performance for our currently marketed brands and key growth areas. Finally, we continue to drive productivity gains across our business in order to adequately fund R&D, invest in the launch of new products, support necessary capital spending, engage in business development and return additional cash to shareholders through our dividend and our share repurchase program." Eli Lilly shares were inactive in pre-market trading. They finished yesterday up 43 cents, or 0.84%.

    The Bottom Line

    Shares of Eli Lilly & Co. (LLY) have a yield of 3.8% based on Monday's closing price of $51.53 and the company's annualized payout of $1.96. Eli Lilly & Co. (LLY)  is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

    Expand to read the full story »

Top-5-pitch